Menu

Attovia Therapeutics, Inc. ATTO

Full chart Compare
Set alert

Price alert · ATTO

All alert types
15.27 USD +0.27 (+1.80%)

At closeNov 6, 2026, 4:00 PM EST

15.27 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

14.93 Day range 15.50
13.73 52-week range 25.55
YTD
-30.27%
1 year
-30.27%

Revenue & Expenses

Other Income → Expenses: $6.53MExpenses → Selling, General & Admin: $14.36MExpenses → Research & Development: $54.15MGross Profit → Expenses: $1.35MRevenue → Gross Profit: $1.35MNet Loss → Expenses: $60.63MOther Income$6.53MGross Profit$1.35MNet Loss$60.63MExpenses$68.51MSelling, General & Admin$14.36MResearch & Development$54.15MRevenue$1.35M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ATTO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
1.35M0
1.35M0
-67.16M-41.55M
-60.63M-39.80M
-15.42-12.76
ATTO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
40.60M31.24M
165.89M76.72M
15.10M14.59M
5.26M0
-107.44M-46.83M
ATTO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-59.20M-35.03M
-73.45M-39.80M
142.01M82.75M
-2.31M-1.77M
9.36M7.91M